DyeVert System and Contrast-induced Acute Kidney Injury

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 522 participants.

Also called NCT04714736

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 522 participants (enrolled count) (from the registry)
Sponsor
Clinica Mediterranea (from the registry)
Registry
  • NCT NCT04714736
Other papers using this trial's data
  • Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes Journal of the American College of Cardiology, 2024-03-19 DOI, PubMed 38479953

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04714736. Randomized; single masking; primary purpose prevention. Start 2020-02-10 (actual); primary completion 2022-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DyeVert System and Contrast-induced Acute Kidney Injury
Acronym
REMEDIALIV
Condition
Contrast-induced Acute Kidney Injury
Condition
Acute Coronary Syndromes
Intervention (Device)
Coronary angiography using DyeVert system
Intervention (Procedure)
Coronary angiography using conventional manual injection syringe.
Lead sponsor
Clinica Mediterranea (class: other)

Record details

Record id
cardio:ct-nct04714736
Content hash
01f212409a86703bf55396de493245f1b3ca9f61c0593c2eac4088f97065ed12